Leflunomide Supplier-Buyer Network — Trade Flow Analysis

Name: Leflunomide Supplier-Buyer Trade Network Dataset — 106+ Indian Exporters, 13+ Importers, 63+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Leflunomide supplier network, Leflunomide buyers, pharmaceutical export India, Leflunomide trade data

TransData Nexus

Leflunomide

India Pharmaceutical Trade Intelligence

$14.9M106 Suppliers63 CountriesHS 30049099

ExportsIndia → UNITED STATES40.5%India → MYANMAR14.2%

ImportsCANADA → India$9.9K GERMANY → India$8.0K

#1 Supplier: ZYDUS LIFESCIENCES #1 Buyer: EVERSANA LIFE

Who Supplies Leflunomide? Top Manufacturers & Buyers 2026 — ZYDUS LIFESCIENCES LIMITED Leads | TransData Nexus | TransData Nexus

1ZYDUS LIFESCIENCES LIMITED

ZYDUS LIFESCIENCES LIMITED is the first-largest Leflunomide exporter from India, with a market share of 25.0% and a total export value of $3.7M across 75 shipments. Their average shipment value of $49.6K is above the market average of $18.2K, suggesting premium or bulk contract pricing.

ZYDUS LIFESCIENCES LIMITED serves 1 named buyer in our database. EVERSANA LIFE SCIENCE SERVICES is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• EVERSANA LIFE SCIENCE SERVICES — $3.7M across 75 shipments (100.0% of this supplier's total exports)

Key Insight: ZYDUS LIFESCIENCES LIMITED's per-shipment value of $49.6K is 172% above the market average of $18.2K, consistent with large-order contracts or value-added formulations.

2TORRENT PHARMACEUTICALS LTD

TORRENT PHARMACEUTICALS LTD is the second-largest Leflunomide exporter from India, with a market share of 8.4% and a total export value of $1.3M across 45 shipments. Their average shipment value of $27.8K is above the market average of $18.2K, suggesting premium or bulk contract pricing.

TORRENT PHARMACEUTICALS LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• JDS CO LTD — $537.5K across 19 shipments (42.9% of this supplier's total exports)

• HATTON NATIONAL BANK PLC — $293.1K across 11 shipments (23.4% of this supplier's total exports)

• JDS CO LTD — $178.5K across 6 shipments (14.3% of this supplier's total exports)

• JDS CO LTD — $161.0K across 6 shipments (12.9% of this supplier's total exports)

• JDS CO LTD — $82.0K across 3 shipments (6.6% of this supplier's total exports)

Key Insight: TORRENT PHARMACEUTICALS LTD's per-shipment value of $27.8K is 53% above the market average of $18.2K, consistent with large-order contracts or value-added formulations.

3EMCURE PHARMACEUTICALS LIMITED

EMCURE PHARMACEUTICALS LIMITED is the third-largest Leflunomide exporter from India, with a market share of 5.7% and a total export value of $843.5K across 91 shipments. Their average shipment value of $9.3K is below the market average of $18.2K, reflecting a high-volume, competitive pricing strategy.

EMCURE PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• EMCURE PHARMA CHILE S P A — $347.5K across 37 shipments (41.2% of this supplier's total exports)

• EMCURE PHARMA CHILE S P A — $253.0K across 27 shipments (30.0% of this supplier's total exports)

• TILLOMED LABORATORIES LTD. — $90.7K across 10 shipments (10.7% of this supplier's total exports)

• TOO ROGERS PHARMA — $81.8K across 9 shipments (9.7% of this supplier's total exports)

• TILLOMED LABORATORIES LTD. — $70.6K across 8 shipments (8.4% of this supplier's total exports)

Key Insight: EMCURE PHARMACEUTICALS LIMITED operates with high shipment frequency (91 shipments) at a per-shipment value of $9.3K, indicating a broad distribution network with many smaller, regular orders.

4ALEMBIC PHARMACEUTICALS LIMITED

ALEMBIC PHARMACEUTICALS LIMITED is the fourth-largest Leflunomide exporter from India, with a market share of 5.3% and a total export value of $781.0K across 87 shipments. Their average shipment value of $9.0K is below the market average of $18.2K, reflecting a high-volume, competitive pricing strategy.

ALEMBIC PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• STADAPHARM GMBH — $239.7K across 27 shipments (30.7% of this supplier's total exports)

• ALLOGA (NEDERLAND) B.V — $202.2K across 23 shipments (25.9% of this supplier's total exports)

• STADAPHARM GMBH — $133.2K across 15 shipments (17.1% of this supplier's total exports)

• J. KNIPPER & COMPANY — $114.6K across 13 shipments (14.7% of this supplier's total exports)

• J. KNIPPER & COMPANY — $91.4K across 10 shipments (11.7% of this supplier's total exports)

Key Insight: ALEMBIC PHARMACEUTICALS LIMITED operates with high shipment frequency (87 shipments) at a per-shipment value of $9.0K, indicating a broad distribution network with many smaller, regular orders.

5CADILA HEALTHCARE LIMITED

CADILA HEALTHCARE LIMITED is the fifth-largest Leflunomide exporter from India, with a market share of 4.7% and a total export value of $699.9K across 10 shipments. Their average shipment value of $70.0K is above the market average of $18.2K, suggesting premium or bulk contract pricing.

CADILA HEALTHCARE LIMITED serves 1 named buyer in our database. EVERSANA LIFE SCIENCE SERVICES is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• EVERSANA LIFE SCIENCE SERVICES — $699.9K across 10 shipments (100.0% of this supplier's total exports)

Key Insight: CADILA HEALTHCARE LIMITED's per-shipment value of $70.0K is 284% above the market average of $18.2K, consistent with large-order contracts or value-added formulations.

6KUSUM HEALTHCARE PRIVATE LIMITED

KUSUM HEALTHCARE PRIVATE LIMITED is the fifth-largest Leflunomide exporter from India, with a market share of 3.7% and a total export value of $543.0K across 56 shipments. Their average shipment value of $9.7K is below the market average of $18.2K, reflecting a high-volume, competitive pricing strategy.

KUSUM HEALTHCARE PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• FE BARAKA DORI FARM — $169.8K across 18 shipments (31.3% of this supplier's total exports)

• GLADPHARM LTD. — $149.8K across 15 shipments (27.6% of this supplier's total exports)

• ATLANTA MEDICARE CO. — $93.8K across 10 shipments (17.3% of this supplier's total exports)

• LLP "DARI-PHARM (KAZAKHSTAN) — $68.8K across 7 shipments (12.7% of this supplier's total exports)

• GLADPHARM LTD. — $60.9K across 6 shipments (11.2% of this supplier's total exports)

Key Insight: KUSUM HEALTHCARE PRIVATE LIMITED operates with high shipment frequency (56 shipments) at a per-shipment value of $9.7K, indicating a broad distribution network with many smaller, regular orders.

1United States

United States ranks as the first-largest destination for Leflunomide imports from India, with a total trade value of $6.0M across 97 shipments — representing a 40.5% share of all Leflunomide exports. The average shipment value of $62.0K is above the global average of $18.2K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.

Named Leflunomide importers in United States: EVERSANA LIFE SCIENCE SERVICES is the largest buyer, accounting for 86.6% ($5.2M) of this market's total imports.

• EVERSANA LIFE SCIENCE SERVICES — $5.2M (86.6% of United States's total)

• XXPINXXHARXXCEUXXCALXXINCX — $173.5K (2.9% of United States's total)

• LUPIN PHARMACEUTICALS INC — $173.1K (2.9% of United States's total)

Key Insight: United States's per-shipment average of $62.0K (240% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Leflunomide imports from India.

Primary Market

Secondary Market

2Myanmar

Myanmar ranks as the second-largest destination for Leflunomide imports from India, with a total trade value of $2.1M across 12 shipments — representing a 14.2% share of all Leflunomide exports. The average shipment value of $175.5K is above the global average of $18.2K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.

Named Leflunomide importers in Myanmar: JDS CO LTD is the largest buyer, accounting for 33.7% ($709.8K) of this market's total imports.

• JDS CO LTD — $709.8K (33.7% of Myanmar's total)

• JDS CO, LTD, — $372.4K (17.7% of Myanmar's total)

• JDS CO. LIMITED — $326.0K (15.5% of Myanmar's total)

Key Insight: Myanmar's per-shipment average of $175.5K (863% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Myanmar is a key market for Leflunomide imports from India.

Primary Market

Secondary Market

3Sri Lanka

Sri Lanka ranks as the third-largest destination for Leflunomide imports from India, with a total trade value of $1.2M across 15 shipments — representing a 8.4% share of all Leflunomide exports. The average shipment value of $83.1K is above the global average of $18.2K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Leflunomide importers in Sri Lanka: NATIONS TRUST BANK PLC. is the largest buyer, accounting for 36.7% ($457.9K) of this market's total imports.

• NATIONS TRUST BANK PLC. — $457.9K (36.7% of Sri Lanka's total)

• HATTON NATIONAL BANK PLC — $293.1K (23.5% of Sri Lanka's total)

Key Insight: Sri Lanka's per-shipment average of $83.1K (356% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Sri Lanka is a key market for Leflunomide imports from India.

Primary Market

Secondary Market

4United Kingdom

United Kingdom ranks as the fourth-largest destination for Leflunomide imports from India, with a total trade value of $778.0K across 48 shipments — representing a 5.2% share of all Leflunomide exports. The average shipment value of $16.2K is below the global average of $18.2K, consistent with generic/API volume purchasing. This market is served by 2 tracked buyers.

Named Leflunomide importers in United Kingdom: TILLOMED LABORATORIES LTD is the largest buyer, accounting for 32.4% ($252.4K) of this market's total imports.

• TILLOMED LABORATORIES LTD — $252.4K (32.4% of United Kingdom's total)

• TILLOMED LABORATORIES LTD. — $214.1K (27.5% of United Kingdom's total)

Key Insight: United Kingdom receives frequent, smaller shipments of Leflunomide — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.

United Kingdom is a key market for Leflunomide imports from India.

Primary Market

Secondary Market

5Chile

Chile ranks as the fifth-largest destination for Leflunomide imports from India, with a total trade value of $732.8K across 27 shipments — representing a 4.9% share of all Leflunomide exports. The average shipment value of $27.1K is above the global average of $18.2K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Leflunomide importers in Chile: EMCURE PHARMA CHILE S.P.A. is the largest buyer, accounting for 51.0% ($373.7K) of this market's total imports.

• EMCURE PHARMA CHILE S.P.A. — $373.7K (51.0% of Chile's total)

• EMCURE PHARMA CHILE S P A — $253.0K (34.5% of Chile's total)

Key Insight: Chile's per-shipment average of $27.1K (49% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Chile is a key market for Leflunomide imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Leflunomide.
2.Flow Mapping: 106 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 816 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 63 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

816 Verified Shipments

106 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Leflunomide

Leflunomide

Who Supplies Leflunomide? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Leflunomide? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Leflunomide Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1ZYDUS LIFESCIENCES LIMITED

2TORRENT PHARMACEUTICALS LTD

3EMCURE PHARMACEUTICALS LIMITED

4ALEMBIC PHARMACEUTICALS LIMITED

5CADILA HEALTHCARE LIMITED

6KUSUM HEALTHCARE PRIVATE LIMITED

From Indian Factories to Global Pharmacies — How Leflunomide Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Leflunomide Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2Myanmar

3Sri Lanka

4United Kingdom

5Chile

People Also Ask — Leflunomide Supplier & Trade Network

Leflunomide Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology